Back to
DEUTSCHE BANK AG\
IKT4 quarters
Position history for
DEUTSCHE BANK AG\'s holdings in INHIBIKASE THERAPEUTICS INC
Yes. Deutsche Bank holds 126,677 shares of IKT (Inhibikase Therapeutics), worth $257,154, as of its Q2 2026 13F filing. It increased the position by 4,235 shares (+3.5%) from Q1 2026. Deutsche Bank has held IKT since Q3 2025, across 4 quarterly 13F filings.
Current Value
$257,154
Current Shares
126,677
Total Value Change
+$126,750
Total Shares Change
+46,181
Quarter-by-Quarter History
Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC